Literature DB >> 24426339

Carrier Screening for β Thalassemia in Pregnant Indian Women: Experience at a Single Center in Madhya Pradesh.

Asha Baxi1, Kaushal Manila1, Pooja Kadhi1, Baxi Heena1.   

Abstract

To study the prevalence of β thalassemia trait in pregnancy in urban population screening for β thalassemia in pregnant women at a single center in Indore (MP) has been conducted for a period of 2 year. Blood samples were tested for complete blood count and hemoglobin electrophoresis. During the 2 year period a total of 1,006 women were screened; 28 women who carried abnormal pattern were detected. The mean gestational age for screening was 13 ± 4 weeks. The prevalence of carriers was 2.78 %. As much as 99 % of pregnant women undergoing screening were willing for prenatal diagnosis if required. The economic burden to the society for treating thalassemic patients is huge. The institution of prevention programs like carrier screening has proven costeffective in populations with a high frequency of carriers. Screening of pregnant women early in pregnancy followed by prenatal diagnosis is acceptable and effective strategy for control of thalassemia in developing countries like India.

Entities:  

Keywords:  Hemoglobinopathies; Pregnancy; β Thalassemia trait

Year:  2012        PMID: 24426339      PMCID: PMC3636359          DOI: 10.1007/s12288-012-0165-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  9 in total

Review 1.  Screening for thalassemia: a model of success.

Authors:  Antonio Cao; Maria Cristina Rosatelli; Giovanni Monni; Renzo Galanello
Journal:  Obstet Gynecol Clin North Am       Date:  2002-06       Impact factor: 2.844

2.  Iranian national thalassaemia screening programme.

Authors:  Ashraf Samavat; Bernadette Modell
Journal:  BMJ       Date:  2004-11-13

3.  Carrier screening for beta-thalassemia during pregnancy in India: a 7-year evaluation.

Authors:  Roshan Colah; Reema Surve; Marukh Wadia; Prakash Solanki; Pramod Mayekar; Mariamma Thomas; Ajit Gorakshakar; Adi Dastur; Dipika Mohanty
Journal:  Genet Test       Date:  2008-06

Review 4.  Beta-thalassemia: the Lebanese experience.

Authors:  A Inati; N Zeineh; H Isma'eel; S Koussa; W Gharzuddine; A Taher
Journal:  Clin Lab Haematol       Date:  2006-08

5.  Distribution and control of some genetic disorders.

Authors:  B Modell; V Bulyzhenkov
Journal:  World Health Stat Q       Date:  1988

Review 6.  Carrier screening and genetic counselling in beta-thalassemia.

Authors:  Antonio Cao
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 7.  The significance of the hemoglobin A(2) value in screening for hemoglobinopathies.

Authors:  Antonino Giambona; Cristina Passarello; Disma Renda; Aurelio Maggio
Journal:  Clin Biochem       Date:  2009-07-08       Impact factor: 3.281

Review 8.  Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience.

Authors:  A Cao; M C Rosatelli; R Galanello
Journal:  Ciba Found Symp       Date:  1996

9.  Beta-thalassemia minor during pregnancy.

Authors:  Eyal Sheiner; Amalia Levy; Ronit Yerushalmi; Miriam Katz
Journal:  Obstet Gynecol       Date:  2004-06       Impact factor: 7.661

  9 in total
  3 in total

1.  Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: a systematic review.

Authors:  Adrina Zhong; Benedict Darren; Bethina Loiseau; Li Qun Betty He; Trillium Chang; Jessica Hill; Helen Dimaras
Journal:  Genet Med       Date:  2018-08-03       Impact factor: 8.822

2.  NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.

Authors:  Manasi Gosavi; Ramesh Chavan; M B Bellad
Journal:  J Lab Physicians       Date:  2021-07-09

3.  Outcome of Pregnancy with Hemoglobinopathy in a Tertiary Care Center.

Authors:  Anahita Chauhan; Madhva Prasad
Journal:  J Obstet Gynaecol India       Date:  2017-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.